SCHEMBL29566963

SCHEMBL29566963

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1C(F)(F)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD52 P43351 1/20 0.36
▸ BRD4 O60885 5/20 0.36
▸ CTSC P53634 2/20 0.35
▸ MAP4K1 Q92918 1/20 0.34
▸ PDE2A O00408 1/20 0.34
▸ PDE10A Q9Y233 1/20 0.34
▸ FGFR4 P22455 2/20 0.34
▸ JAK2 O60674 3/20 0.33
▸ FLT3 P36888 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ITK Q08881 1/20 0.33
▸ TACR1 P25103 1/20 0.33
▸ BUB1B O60566 1/20 0.33
▸ RET P07949 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ BRD2 P25440 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310187 1.00 RAD52 (0.36) RAD52BRD4CTSCMAP4K1PDE2A
SCHEMBL24310167 0.93 RAD52 (0.37) RAD52BRD4CTSCMAP4K1PDE2A
SCHEMBL29566354 0.93 RAD52 (0.37) RAD52BRD4CTSCMAP4K1PDE2A
SCHEMBL29566715 0.93 HTR1A (0.38) RAD52BRD4CTSCFGFR4JAK2
SCHEMBL24310777 0.93 HTR1A (0.38) RAD52BRD4CTSCFGFR4JAK2
SCHEMBL24310157 0.92 RAD52 (0.38) RAD52BRD4MAP4K1PDE2APDE10A
SCHEMBL29566851 0.92 RAD52 (0.38) RAD52BRD4MAP4K1PDE2APDE10A
SCHEMBL24310530 0.92 RAD52 (0.34) RAD52BRD4CTSCMAP4K1FGFR4
SCHEMBL29566997 0.92 RAD52 (0.34) RAD52BRD4CTSCMAP4K1FGFR4
SCHEMBL24310143 0.91 TACR1 (0.38) RAD52BRD4CTSCALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback